Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study finds
Semaglutide, a common ingredient in GLP-1 weight-loss medications, is associated with lower risks of worsening mental disorders, according to a new study. ADVERTISEMENT ADVERTISEMENT The research, published in The Lancet Psychiatry, found that people following a GLP-1 treatment for diabetes and obesity had a lower need for hospital care and medical leave due to psychiatric … Read more